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Background: A novel human enterovirus (HEV) type within the species HEV-C, named EV109, was discovered from
cases of respiratory illness in Nicaragua in September 2010. The aim of this study, was to retrospectively examine
the presence and the role of EV109 in respiratory samples from two patients populations; infants below the age of
2 years, hospitalized for acute respiratory diseases (ARDs) and adult hematopoietic stem cell transplantation recipients.
Results: A total of 1149 nasopharingeal aspirates were collected and tested for the presence of EV109 by reverse
transcription-PCR (RT-PCR). In positive samples, the presence of the most common respiratory viruses was also assayed
and clinical symptoms were evaluated. Samples from 2 of the 974 infants tested positive for EV109 RNA (0.2%) and
belonged to patients with lower ARDs; co-infection with other viral pathogens under study was observed in both
cases. In transplant recipients, one out of the 175 samples analyzed, from a patients with upper respiratory simptoms
tested positive for HEV 109 in the absence of co-infecting viruses. Sequence analysis of amplified EV109 genomic
regions, showed only a few nucleotide differences when compared with the Nicaraguan strains.
Conclusions: Overall these results indicate that HEV109 variants have circulated and differentiated in different lineages
worldwide. Although more cases and larger studies are needed, HEV109 infection may be associated to ARDs both in
infants and in hematopoietic stem cell transplantation recipients. If these preliminary observations will be confirmed,
improved molecular methods with a wider panel of potential pathogens will be useful for monitoring these categories
of patients.
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Human enteroviruses (HEV) belonging to the Picornaviri-
dae family are ubiquitous viruses responsible for a wide
range of clinical syndromes ranging from mild respiratory
symptoms to serious conditions, including aseptic menin-
gitis, encephalitis and acute flaccid paralysis. Some sero-
types support respiratory infections, and it has been
confirmed that they are responsible for bronchopneumo-
nias and occasional fatal cases [1-4]. As for many RNA
viruses, the genetic evolution of HEV occurs over time by
means of point mutations and recombination phenomena* Correspondence: canducci.filippo@hsr.t
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reproduction in any medium, provided the orallowing the virus to adapt to environment modifications
and host selective pressure [2,5,6]. This genetic evolution
is linked directly to virulence characteristics, tissue trop-
ism and hence to the pathogenic potential of these viruses
[5,7]. More than 100 different serotypes of non polio
enteroviruses have been recognized and recently two new
enterovirus, the HEV104 and the HEV109, classified
within HEV species C, were reported in association with
respiratory diseases [8].
HEV104 was identified in 2009 in Switzerland and later
in other Countries often in association with respiratory
signs [3,9]. HEV109 was molecularly identified in 2010 in
the nose and throat swab samples collected between June
2007 and June 2008 from children enrolled in a cohortal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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also associated with enteric symptoms [10].
After the identification of these novel HEVs, another
species C HEV distantly related to EV109 was retrieved
from a rectal swab of a deceased patient during an out-
break of flaccid paralysis in Congo; in this sample polio-
virus and other neurologic, enteric and respiratory viral
pathogens were not detected [8].
The global distribution of HEV109 is currently un-
known and no studies have been performed yet to
evaluate the epidemiological features of this infection.
Furthermore, extensive screening in different patients
populations with different clinical syndromes is needed
to establish the full spectrum of HEV109 disease associ-
ation and evaluate its pathogenetic potential.
In this study we looked for the presence of HEV109 in
respiratory samples from two patients populations; i)
infants less than 2 years old, hospitalized for acute respira-
tory tract diseases (ARDs) and ii) adult immunosup-
pressed hematopoietic stem cell transplantation recipients
where sequential nasopharyngeal aspirates were evaluated.
Results
Respiratory samples obtained from 974 infants (age
range 1 to 24 months; mean age 4 months) hospitalised
from October 2004 to November 2010, were evaluated
for the presence of HEV109. Diagnosis at admission was
lower acute respiratory disease (L-ARD) in 759 of the
974 patients (78%) [bronchiolitis in 468 (48%), bronchitis
in 156 (16%) and bronchopneumonia in 135 (14%)] and
upper respiratory tract disease (U-RTD; including rhin-
itis, laryngitis and upper respiratory tract phlogosis) in
the remaining 215 patients (22%). Samples from 2 of the
974 infants tested positive for HEV109 RNA (0.2%) and
belonged to patients diagnosed with L-ARD. The two
HEV109 positive children were 3 and 6 months old and
samples were collected in November 2005 and January
2006. Clinical features of HEV109 positive infants are
reported in Table 1. Co-infections with other viral
pathogens were observed in both cases. In particular, in
one case HRV was also identified and in the other
HEV109 positive case a triple infection was observed
with RSV and HRV. All samples taken from October
2004 to September 2006 had also been evaluated for the
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pharingodinia pPolyomaviruses genomes, in previous studies [11-13]. Of
the 322 samples from this period, 90 (28%) were positive
for RSV RNA, 48 (14.3%) for hMPV RNA, 28 for hCoV
RNA (8.7%) [11 for OC43 (3.3%), 9 for NL63 (2.8%), 6
for HKU1 (1.9) and 1 for 229E (0.3%)] and 7 (2.2%) for
hBoV DNA. Considering the 322 evaluations of this epi-
demic period, the prevalence of HEV109 resulted 0.6%
and the virus circulated during the RSV epidemic peak
contemporarily with hMPV and hCoV.
In the transplant recipient group, only one out of the
175 samples evaluated, tested positive for HEV109 infec-
tion. In particular, the presence of HEV109 was documen-
ted in a sample collected 180 days after transplantation in
February 2006. Sixteen out of the 54 patients suffered of
an episode of upper respiratory symptoms during the
study (rhinorrhea, pharingodinia, tussis). From these
patients, 58 samples were collected and 18 out of the 58
samples were collected during respiratory symptoms. The
HEV109 positive patient was referring upper respiratory
symptoms including pharingodinia lasting several days,
but no gastrointestinal symptoms were recorded.
Attempts to identify other co-infecting viruses including
the HRV-C strain in the HEV109 positive sample gave
negative results.
Notably, all three amplification protocols, including
the HRV amplification protocol (that uses degenerated
primers to amplify all rhinovirus and theoretically also
several other Picornaviruses as suggested by sequence
alignment and unpublished observations), used in the
present study were able to detect HEV109 infection. Dis-
tinct agarose gel electrophoresis patterns and sequencing
of individually gel extracted amplicons, allowed to ex-
clude (in the transplant recipient sample) or confirm (in
pediatric samples) co-infection of HEV109 with HRV
(Table 1).
Unfortunately the low number of HEV109 positive
samples could not allowed a reliable statistical analysis
of the severity of the infection or co-infection in com-
parison to other respiratory viruses in both populations
as described in previous papers for other recently identi-
fied pathogens [11,12].
Analysis of 950 bases along the UTR, the VP4 and
VP2 sequences (Figure 1) (GenBank accession numbers
JX006784-9) indicated that, when compared, while the
three identified HEV109 strains resulted almost identicallant patient




ronchiolitis / 3 hRV
sthmatic bronchitis / 6 RSV, hRV
haringodinia /
Debiaggi et al. Virology Journal 2012, 9:183 Page 3 of 6
http://www.virologyj.com/content/9/1/183(less than 1% nucleotide difference), HEV109 Nicaraguan
strains resulted 6.5% and 4% different in nucleotide and
amino acid sequences respectively when compared with
our strains (Figure 2).
Discussion
In February 2006 the novel HEV109 was identified in a
symptomatic immunocompromised adult from a respira-
tory sample collected in Italy. This is the first report of
this virus in a transplanted patient with respiratory
symptoms. The retrospective evaluation carried out in a
pediatric department in the same geographic area
throughout a period of six years proves that in infants
below two years old and hospitalised for ARDs, the cir-
culation of EV109 was low (0.2%) and concentrated in a
the same period (November 2005-February 2006) sug-
gesting that the newly identified enterovirus may cause
sporadic epidemics in northern Italy. The sequence ana-
lysis performed on 950 bases along the UTR, the VP4
and VP2 regions showed only a few differences in the
nucleotide sequence of our strains compared with the
Nicaragua strains. The UTR amplified region crosses the
putative area of recombination that was observed in
HEV109 and the limited variability observed suggests
that this recombination is very old and that this strain
has circulated worldwide [10].
Some results may point towards a possible role of this
virus as co-pathogen in ARDs in infants. In fact, in the
paediatric cases of this study, even if with other co-infec-
tions, EV109 was only detected in samples from infants
with L-ARD. Moreover, we observed a very low differ-
ence in amino acid sequences between isolates of this
study and those described in Nicaragua in symptomatic
patients. However we must underling that since 78% of
our pediatric samples were from infants with lower tract
disease, we cannot exclude a population bias in our
observations and more cases of HEV109 infections and
larger studies are needed to definitively clarify this point.
In fact no HEV109 single infections were observed in
pediatric patients and the limited number of HEV109
cases didn’t allows a statistically significant comparison
of HEV109 co-infection severity compared to HEV109
negative co-infections as we described in previous
papers for other pathogens [11,12].
The tedious pharingodinia suffered by the adult im-
munocompromised patient where HEV109 was isolatedFigure 1 Mapping of the amplified regions on the reference sequence ofin the absence of other co-infecting respiratory viruses
suggesting a direct pathogenetic role of this virus as
speculated in initial observations [10]. Other pathogens,
including HRV infections were common and as previ-
ously documented for hMPV [13,14], frequently asymp-
tomatic in this group of patients, including the majority
of rhinoviruses infections due to HRV-C strain (data not
shown). Respiratory syndromes were indeed not com-
mon in transplant recipients and only 16 out of 54
transplant patients suffered sporadic episodes of upper
respiratory symptoms. As recently suggested however,
since symptomatic and also asymptomatic viral infec-
tions can trigger acute rejection and obliterative bron-
chiolitis in lung transplant recipients [15] the role of this
new HEV needs to be clearly elucidated.
Conclusions
These results, even if only partial genome sequences were
analyzed and larger cohorts may be needed, suggest that
HEV109 variants have circulated and differentiated in dif-
ferent lineages worldwide and can be associated to ARDs
both in infants and in hematopoietic stem cell transplant-
ation recipients. Although these initial observations can-
not be conclusive on the pathogenic potential of this novel
strain, an always wider panel of potential pathogens may
be needed for a continuous monitoring of immunocom-
promised patients and for a better epidemiological
characterization of respiratory infections in infants.
Methods
The present study was approved by the Istituto di ricov-
ero e Cura a Carattere Scientifico (IRCCS) Policlinico
San Matteo Ethical Committee, and informed consent
was obtained from parents or guardians in compliance
with the Helsinki Declaration and for the consent to
publish individual clinical data (Table 1).
Pediatric samples. A total of 974 archived nasopharyn-
geal aspirates (NPA) from children <24 months old
and hospitalized for ARDs (mainly bronchiolitis, pneu-
monia, bronchitis, bronchospasm or wheezing) were
examined in the present study. Samples were collected
from October 2004 to November 2010, at the micro-
biology laboratory of the Azienda Ospedaliera in
Melegnano. Samples collected during the 2004–2006
period were part of previous studies to characterize the
infections of human respiratory syncytial virus (HRSV)Human enterovirus 109 (GenBank accession number: NC_014336).
Figure 2 Typing of HEV109 strains identified in pediatric patients and hematopoietic stem cell transplant recipients (indicated by
black dots). Phylogenetic relationships were estimated using neighbor-joining method with the Tajima-Nei model as described in the methods.
Reference sequences were used to generate the alignment (http://www.picornastudygroup.com). Pediatric or transplant HEV109 strains are
indicated with -ped or with -tr suffix respectively
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with ARDs [11,12]. In all cases NPAs were collected as
part of the standard diagnostic practice to assess the
presence of HRSV. Clinical data including comorbidities
or subsequent bacterial infections, the duration of
hospitalization, the presence of hypoxia, fever >38°C or
gastrointestinal symptoms at the time of diagnosis were
also available for most infants.
Transplant recipients’ samples. A total of 175 archived
NPAs were obtained from 50 allogeneic and 4 autolo-
gous haematopoietic stem cell transplant recipient
patients recruited at the Division of Hematology, IRCCS
Policlinico San Matteo (Pavia, Italy) regardless of re-
spiratory symptoms, as described [13,14]. Respiratory
samples were consecutively obtained after informed con-
sent from October 1st, 2004 to April 2007. One to nine
samples from each patient were collected every 30 days
up to 180 days after transplantation. At each time point
clinical data were recorded.
All samples were extracted by using Qiagen RNA mini
kit (Qiagen, Germany), in accordance with the manufac-
turer’s protocol.
To investigate the prevalence of HEV109 in children
and haematopoietic stem cell transplant recipient patients,specific primers targeting the UTR region were used
(EV109 VP1 123 F, 50-GGA GAC TGG AGC AAC TAG
TAA AG-30; EV109 VP1 363R, 50-GGT GAA CAT TTC
CAATTT CCT ACG-30). To better characterize the novel
HEV 109 strains the VP4/VP2 region was also amplified
using the following primers: P2-4-Rw GCA TCI GGY
ARY TTC CAC CAC CAN CC; VP2-4-Fw GGG ACC
AAC TAC TTT GGG TGT CCG TGT (Figure 2). The
sensitivity of amplification protocols was determined by
cloning each amplified target regions into pCR2.1 plasmid
vector (TA Cloning Kit; Invitrogen), serially diluted from
106 copies to 1 copy as previously described [11,13,16]
Amplification protocols ensured the detection of 5 and 15
DNA copies/reaction of HEV109 target regions respect-
ively (data not shown).
After agarose gel electrophoresis visualization, all the
amplification products were sequenced bidirectionally to
confirm amplification specificity. Molecular identifica-
tion and typing of HEV109 positive samples, were per-
formed with MEGA 3.1 software after ClastalW
alignment and manual sequence editing with BioEdit.
Phylogenetic relationships were estimated using MEGA
V3.1, (neighbor-joining method by using Tajima-Nei
model as estimated by using Modeltest; the α value used
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data by using PAUP).
Since multiple infections are frequently detected in re-
spiratory samples of patients with respiratory symptoms
and to better clarify the pathogenetic role of the novel en-
terovirus in co-infections, all specimens positive for
HEV109 were also assayed for the presence of other re-
spiratory viruses, including parainfluenza viruses (PIV 1–3),
influenza A and B viruses, human metapneumovirus
(HMPV), human respiratory syncytial virus (HRSV), ade-
noviruses, human coronaviruses (hCoV), human boca-
virus (hBoV) and for WU (WUPyV) and KI (KIPyV)
polyomaviruses using a multiplex PCR strategy (Seeplex
RV12 ACE Detection, Seegene, Rockville) and in house
protocols [11-13]. Presence of human rhinoviruses (HRVs)
in HEV109 positive samples from infants and in all sam-
ples from immunosuppressed patients were also in-
vestigated by molecular analysis and phylogenetic recon-
struction. Samples were subjected to first round one step
reverse transcription and amplification (Super-ScriptIII
One Step RT-PCR with Platinum Taq (Invitrogen) after
RNA extraction using Primers P1-1 (CAA GCA CTT
CTG TYW CCC C) and P3-1 (ACG GAC ACC CAA
AGT AG) and the following thermal profile: 20 min 50°C,
10 min 95°C, followed by 15 'touchdown' cycles (The steps
were 94°C for 20 s, 68°C down to 52°C (2°C intervals) for
30 s), and 25 cycles at 94°C 30 s, 52°C 30 s and a final
extention step at 68°C for 40 s.; 5 μl of first RT-PCR reac-
tion underwent a semi-nested amplification using the Plat-
inum TaqDNA Polimerase (Invitrogen) and the forward
primer P1-1 and three reversed primers P2-1 (TTA GCC
ACA TTC AGG GGC), P2-2 (TTA GCC ACA TTC AGG
AGC C) and P2-3 (TTA GCC GCA TTC AGG GG) as
described previously with minor modifications [17]. In all
amplification protocols primers were used at a final con-
centration of 200 nM. Amplification specificity was con-
firmed by sequencing and phylogenetic internal control
used to exclude contaminations [18,19].
Since this amplification protocol amplified also
HEV109 homologous target sequence, in co-infected
samples, amplifications products after gel electrophor-
esis (data not shown) were individually gel extracted
(using Qiagen mini elute gel extraction kit) and
sequenced to confirm amplification specificity. In all
HRV samples when visualized in the gel only the nested
amplification product of about 300 bp was observed. In
the co-infected samples instead, after both amplification
reaction, an additional 390 bp band was indeed always
present that when sequenced independently corre-
sponded to the HEV109 genome amplified with the
outer primers. We cannot exclude that a deeper clonal
analyses of each band would have demonstrated the
presence of both viruses in both amplification products,
however in the mono-infected transplant recipientpatient the inner amplification product corresponded to
the HEV only when sequenced.
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